Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (Diluted Average) (2019 - 2025)

Collegium Pharmaceutical has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $40.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $40.1 million for Q4 2025, down 0.86% from a year ago — trailing twelve months through Dec 2025 was $40.1 million (down 0.86% YoY), and the annual figure for FY2025 was $40.1 million, down 0.86%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $40.1 million at Collegium Pharmaceutical, up from $39.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for COLL hit a ceiling of $41.8 million in Q4 2023 and a floor of $32.8 million in Q1 2025.
  • Median Shares Outstanding (Diluted Average) over the past 3 years was $40.2 million (2024), compared with a mean of $39.5 million.
  • Peak annual rise in Shares Outstanding (Diluted Average) hit 0.86% in 2025, while the deepest fall reached 20.75% in 2025.
  • Collegium Pharmaceutical's Shares Outstanding (Diluted Average) stood at $41.8 million in 2023, then fell by 3.26% to $40.4 million in 2024, then dropped by 0.86% to $40.1 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $40.1 million (Q4 2025), $39.4 million (Q3 2025), and $39.1 million (Q2 2025) per Business Quant data.